世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

破壊的行動障害(DBD)の世界市場の洞察と2028年までの予測

破壊的行動障害(DBD)の世界市場の洞察と2028年までの予測


Global Disruptive Behavior Disorders (DBD) Market Insights and Forecast to 2028

破壊的行動障害(Disruptive Behavior Disorders: DBD)とは、子供や青年が他者に向ける敵対的、反抗的な行動を特徴とする行動障害です。 市場分析と洞察。破壊的行動障害(DBD)の世界市場 破壊的行動障害(DB... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2022年1月21日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

破壊的行動障害(Disruptive Behavior Disorders: DBD)とは、子供や青年が他者に向ける敵対的、反抗的な行動を特徴とする行動障害です。
市場分析と洞察。破壊的行動障害(DBD)の世界市場
破壊的行動障害(DBD)の世界市場規模は、2021年の百万米ドルから2028年には百万米ドルに達すると予測され、2022年から2028年の間、年率%で推移すると予測されています。
世界の破壊的行動障害市場は、併存する障害の数の増加、認知度向上のためのNGOや政府のプログラムの積極的な関与によって牽引されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の破壊的行動障害(DBD)市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つよう、見事な試みを行っています。本レポートの購入者は、破壊的行動障害(DBD)の世界市場全体の規模(売上高)など、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、破壊的行動障害(DBD)の世界市場において、競合他社に対して優位に立ち、永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の破壊的行動障害(DBD)市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。
世界の破壊的行動障害(DBD)の範囲と市場規模
破壊的行動障害(DBD)市場は、プレイヤー別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界の破壊的行動障害(DBD)市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てています。
タイプ別セグメント
刺激性物質
非刺激剤
アプリケーション別セグメント
行動障害(CD)
反抗期障害(ODD)
会社別
Eli Lilly
Bionomics
チェルシー・セラピューティクス
ファイザー
ジョンソン・エンド・ジョンソン
デュレクト
ノバルティス
McNeil Pharmaceuticals
サノビオン社
ニューリバー社
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stimulants
1.2.3 Non-stimulants
1.3 Market by Application
1.3.1 Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Conduct Disorder (CD)
1.3.3 Oppositional Defiant Disorder (ODD)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Disruptive Behavior Disorders (DBD) Market Perspective (2017-2028)
2.2 Disruptive Behavior Disorders (DBD) Growth Trends by Region
2.2.1 Disruptive Behavior Disorders (DBD) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Disruptive Behavior Disorders (DBD) Historic Market Size by Region (2017-2022)
2.2.3 Disruptive Behavior Disorders (DBD) Forecasted Market Size by Region (2023-2028)
2.3 Disruptive Behavior Disorders (DBD) Market Dynamics
2.3.1 Disruptive Behavior Disorders (DBD) Industry Trends
2.3.2 Disruptive Behavior Disorders (DBD) Market Drivers
2.3.3 Disruptive Behavior Disorders (DBD) Market Challenges
2.3.4 Disruptive Behavior Disorders (DBD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Disruptive Behavior Disorders (DBD) Players by Revenue
3.1.1 Global Top Disruptive Behavior Disorders (DBD) Players by Revenue (2017-2022)
3.1.2 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Players (2017-2022)
3.2 Global Disruptive Behavior Disorders (DBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Disruptive Behavior Disorders (DBD) Revenue
3.4 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio
3.4.1 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Disruptive Behavior Disorders (DBD) Revenue in 2021
3.5 Disruptive Behavior Disorders (DBD) Key Players Head office and Area Served
3.6 Key Players Disruptive Behavior Disorders (DBD) Product Solution and Service
3.7 Date of Enter into Disruptive Behavior Disorders (DBD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Disruptive Behavior Disorders (DBD) Breakdown Data by Type
4.1 Global Disruptive Behavior Disorders (DBD) Historic Market Size by Type (2017-2022)
4.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Type (2023-2028)
5 Disruptive Behavior Disorders (DBD) Breakdown Data by Application
5.1 Global Disruptive Behavior Disorders (DBD) Historic Market Size by Application (2017-2022)
5.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
6.2 North America Disruptive Behavior Disorders (DBD) Market Size by Type
6.2.1 North America Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
6.2.2 North America Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
6.2.3 North America Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
6.3 North America Disruptive Behavior Disorders (DBD) Market Size by Application
6.3.1 North America Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
6.3.2 North America Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
6.3.3 North America Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
6.4 North America Disruptive Behavior Disorders (DBD) Market Size by Country
6.4.1 North America Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
6.4.2 North America Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
7.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Type
7.2.1 Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
7.2.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
7.2.3 Europe Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
7.3 Europe Disruptive Behavior Disorders (DBD) Market Size by Application
7.3.1 Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
7.3.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
7.3.3 Europe Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
7.4 Europe Disruptive Behavior Disorders (DBD) Market Size by Country
7.4.1 Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
7.4.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
8.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Type
8.2.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
8.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Application
8.3.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
8.4 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region
8.4.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
9.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Type
9.2.1 Latin America Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
9.2.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
9.2.3 Latin America Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
9.3 Latin America Disruptive Behavior Disorders (DBD) Market Size by Application
9.3.1 Latin America Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
9.3.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
9.3.3 Latin America Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
9.4 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country
9.4.1 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
9.4.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
10.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Type
10.2.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
10.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Application
10.3.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
10.4 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country
10.4.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Disruptive Behavior Disorders (DBD) Introduction
11.1.4 Eli Lilly Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.1.5 Eli Lilly Recent Developments
11.2 Bionomics
11.2.1 Bionomics Company Details
11.2.2 Bionomics Business Overview
11.2.3 Bionomics Disruptive Behavior Disorders (DBD) Introduction
11.2.4 Bionomics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.2.5 Bionomics Recent Developments
11.3 Chelsea Therapeutics
11.3.1 Chelsea Therapeutics Company Details
11.3.2 Chelsea Therapeutics Business Overview
11.3.3 Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Introduction
11.3.4 Chelsea Therapeutics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.3.5 Chelsea Therapeutics Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Disruptive Behavior Disorders (DBD) Introduction
11.4.4 Pfizer Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.4.5 Pfizer Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Disruptive Behavior Disorders (DBD) Introduction
11.5.4 Johnson & Johnson Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 DURECT
11.6.1 DURECT Company Details
11.6.2 DURECT Business Overview
11.6.3 DURECT Disruptive Behavior Disorders (DBD) Introduction
11.6.4 DURECT Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.6.5 DURECT Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Disruptive Behavior Disorders (DBD) Introduction
11.7.4 Novartis Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 McNeil Pharmaceuticals
11.8.1 McNeil Pharmaceuticals Company Details
11.8.2 McNeil Pharmaceuticals Business Overview
11.8.3 McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
11.8.4 McNeil Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.8.5 McNeil Pharmaceuticals Recent Developments
11.9 Sunovion Pharmaceuticals
11.9.1 Sunovion Pharmaceuticals Company Details
11.9.2 Sunovion Pharmaceuticals Business Overview
11.9.3 Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
11.9.4 Sunovion Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.9.5 Sunovion Pharmaceuticals Recent Developments
11.10 New River Pharmaceuticals
11.10.1 New River Pharmaceuticals Company Details
11.10.2 New River Pharmaceuticals Business Overview
11.10.3 New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
11.10.4 New River Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.10.5 New River Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る


 

Summary

Disruptive Behavior Disorders (DBD) is behavioral disorders characterized by hostile and defiant behaviors that children and adolescents direct towards others.
Market Analysis and Insights: Global Disruptive Behavior Disorders (DBD) Market
The global Disruptive Behavior Disorders (DBD) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
The global disruptive behavior disorders market is being driven by the rise in the number of comorbid disorders, active involvement of NGO and government programs to increase awareness.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Disruptive Behavior Disorders (DBD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Disruptive Behavior Disorders (DBD) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Disruptive Behavior Disorders (DBD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Disruptive Behavior Disorders (DBD) market.
Global Disruptive Behavior Disorders (DBD) Scope and Market Size
Disruptive Behavior Disorders (DBD) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Disruptive Behavior Disorders (DBD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Stimulants
Non-stimulants
Segment by Application
Conduct Disorder (CD)
Oppositional Defiant Disorder (ODD)
By Company
Eli Lilly
Bionomics
Chelsea Therapeutics
Pfizer
Johnson & Johnson
DURECT
Novartis
McNeil Pharmaceuticals
Sunovion Pharmaceuticals
New River Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stimulants
1.2.3 Non-stimulants
1.3 Market by Application
1.3.1 Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Conduct Disorder (CD)
1.3.3 Oppositional Defiant Disorder (ODD)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Disruptive Behavior Disorders (DBD) Market Perspective (2017-2028)
2.2 Disruptive Behavior Disorders (DBD) Growth Trends by Region
2.2.1 Disruptive Behavior Disorders (DBD) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Disruptive Behavior Disorders (DBD) Historic Market Size by Region (2017-2022)
2.2.3 Disruptive Behavior Disorders (DBD) Forecasted Market Size by Region (2023-2028)
2.3 Disruptive Behavior Disorders (DBD) Market Dynamics
2.3.1 Disruptive Behavior Disorders (DBD) Industry Trends
2.3.2 Disruptive Behavior Disorders (DBD) Market Drivers
2.3.3 Disruptive Behavior Disorders (DBD) Market Challenges
2.3.4 Disruptive Behavior Disorders (DBD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Disruptive Behavior Disorders (DBD) Players by Revenue
3.1.1 Global Top Disruptive Behavior Disorders (DBD) Players by Revenue (2017-2022)
3.1.2 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Players (2017-2022)
3.2 Global Disruptive Behavior Disorders (DBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Disruptive Behavior Disorders (DBD) Revenue
3.4 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio
3.4.1 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Disruptive Behavior Disorders (DBD) Revenue in 2021
3.5 Disruptive Behavior Disorders (DBD) Key Players Head office and Area Served
3.6 Key Players Disruptive Behavior Disorders (DBD) Product Solution and Service
3.7 Date of Enter into Disruptive Behavior Disorders (DBD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Disruptive Behavior Disorders (DBD) Breakdown Data by Type
4.1 Global Disruptive Behavior Disorders (DBD) Historic Market Size by Type (2017-2022)
4.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Type (2023-2028)
5 Disruptive Behavior Disorders (DBD) Breakdown Data by Application
5.1 Global Disruptive Behavior Disorders (DBD) Historic Market Size by Application (2017-2022)
5.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
6.2 North America Disruptive Behavior Disorders (DBD) Market Size by Type
6.2.1 North America Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
6.2.2 North America Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
6.2.3 North America Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
6.3 North America Disruptive Behavior Disorders (DBD) Market Size by Application
6.3.1 North America Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
6.3.2 North America Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
6.3.3 North America Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
6.4 North America Disruptive Behavior Disorders (DBD) Market Size by Country
6.4.1 North America Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
6.4.2 North America Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
7.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Type
7.2.1 Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
7.2.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
7.2.3 Europe Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
7.3 Europe Disruptive Behavior Disorders (DBD) Market Size by Application
7.3.1 Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
7.3.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
7.3.3 Europe Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
7.4 Europe Disruptive Behavior Disorders (DBD) Market Size by Country
7.4.1 Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
7.4.2 Europe Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
8.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Type
8.2.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
8.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Application
8.3.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
8.4 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region
8.4.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
9.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Type
9.2.1 Latin America Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
9.2.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
9.2.3 Latin America Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
9.3 Latin America Disruptive Behavior Disorders (DBD) Market Size by Application
9.3.1 Latin America Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
9.3.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
9.3.3 Latin America Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
9.4 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country
9.4.1 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
9.4.2 Latin America Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size (2017-2028)
10.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Type
10.2.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Share by Type (2017-2028)
10.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Application
10.3.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Share by Application (2017-2028)
10.4 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country
10.4.1 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Disruptive Behavior Disorders (DBD) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Disruptive Behavior Disorders (DBD) Introduction
11.1.4 Eli Lilly Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.1.5 Eli Lilly Recent Developments
11.2 Bionomics
11.2.1 Bionomics Company Details
11.2.2 Bionomics Business Overview
11.2.3 Bionomics Disruptive Behavior Disorders (DBD) Introduction
11.2.4 Bionomics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.2.5 Bionomics Recent Developments
11.3 Chelsea Therapeutics
11.3.1 Chelsea Therapeutics Company Details
11.3.2 Chelsea Therapeutics Business Overview
11.3.3 Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Introduction
11.3.4 Chelsea Therapeutics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.3.5 Chelsea Therapeutics Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Disruptive Behavior Disorders (DBD) Introduction
11.4.4 Pfizer Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.4.5 Pfizer Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Disruptive Behavior Disorders (DBD) Introduction
11.5.4 Johnson & Johnson Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 DURECT
11.6.1 DURECT Company Details
11.6.2 DURECT Business Overview
11.6.3 DURECT Disruptive Behavior Disorders (DBD) Introduction
11.6.4 DURECT Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.6.5 DURECT Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Disruptive Behavior Disorders (DBD) Introduction
11.7.4 Novartis Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 McNeil Pharmaceuticals
11.8.1 McNeil Pharmaceuticals Company Details
11.8.2 McNeil Pharmaceuticals Business Overview
11.8.3 McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
11.8.4 McNeil Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.8.5 McNeil Pharmaceuticals Recent Developments
11.9 Sunovion Pharmaceuticals
11.9.1 Sunovion Pharmaceuticals Company Details
11.9.2 Sunovion Pharmaceuticals Business Overview
11.9.3 Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
11.9.4 Sunovion Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.9.5 Sunovion Pharmaceuticals Recent Developments
11.10 New River Pharmaceuticals
11.10.1 New River Pharmaceuticals Company Details
11.10.2 New River Pharmaceuticals Business Overview
11.10.3 New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
11.10.4 New River Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
11.10.5 New River Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:656 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_691bfc6385f1a6_84759766() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(279): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_692699f4c96f34_07360116() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 656